Sivik Global Healthcare’s Bruker BRKR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-65,000
Closed -$3.06M 38
2025
Q4
$3.06M Buy
65,000
+5,000
+8% +$211K 0.89% 42
2025
Q3
$1.95M Buy
+60,000
New +$2.14M 0.57% 43
2024
Q3
Sell
-40,000
Closed -$2.55M 38
2024
Q2
$2.55M Buy
+40,000
New +$3.01M 0.92% 37
2021
Q4
Sell
-75,000
Closed -$5.86M 47
2021
Q3
$5.86M Sell
75,000
-20,000
-21% -$1.66M 1.4% 28
2021
Q2
$7.22M Buy
95,000
+15,000
+19% +$1.05M 1.41% 20
2021
Q1
$5.14M Buy
+80,000
New +$4.81M 1.88% 30
2017
Q4
Sell
-50,000
Closed -$1.49M 71
2017
Q3
$1.49M Buy
+50,000
New +$1.44M 0.51% 65
2014
Q2
Sell
-88,400
Closed -$2.02M 72
2014
Q1
$2.02M Buy
88,400
+18,400
+26% +$401K 1.26% 40
2013
Q4
$1.38M Buy
+70,000
New +$1.37M 0.98% 48

Other funds holding BRKR

Sivik Global Healthcare's BRKR Position: Q1 2026 in Review

Sivik Global Healthcare sold out of Bruker (BRKR) in Q1 2026, closing a stake of 65,000 shares — an estimated $3.06M sold.

Sivik Global Healthcare first reported a position in BRKR in Q4 2013 and held it in 9 quarters. The position peaked at $7.22M in Q2 2021. 343 funds tracked by Wall St. Rank hold BRKR as of Q1 2026.

  • Sivik Global Healthcare reported no remaining Bruker position as of Q1 2026 after selling out during the quarter.
  • Sivik Global Healthcare sold 65,000 Bruker shares in Q1 2026, an estimated $3.06M.
  • Sivik Global Healthcare first reported a position in Bruker in Q4 2013 and held it in 9 quarters.
  • Sivik Global Healthcare's Bruker position peaked at $7.22M in Q2 2021.
  • 343 funds tracked by Wall St. Rank held Bruker as of Q1 2026.

Based on Sivik Global Healthcare's 13F filing for Q1 2026, filed 15 Apr 2026.